Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats.

Lim WY, Chia YY, Liong SY, Ton SH, Kadir KA, Husain SN.

Lipids Health Dis. 2009 Jul 29;8:31. doi: 10.1186/1476-511X-8-31.

2.
3.

Lipoprotein lipase: from gene to obesity.

Wang H, Eckel RH.

Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E271-88. doi: 10.1152/ajpendo.90920.2008. Epub 2009 Mar 24. Review.

4.

Obesity and dyslipidemia.

Franssen R, Monajemi H, Stroes ES, Kastelein JJ.

Endocrinol Metab Clin North Am. 2008 Sep;37(3):623-33, viii. doi: 10.1016/j.ecl.2008.06.003. Review.

PMID:
18775355
5.

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.

Adiels M, Olofsson SO, Taskinen MR, Borén J.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1225-36. doi: 10.1161/ATVBAHA.107.160192. Review.

6.

Metabolic syndrome pandemic.

Grundy SM.

Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36. doi: 10.1161/ATVBAHA.107.151092. Epub 2008 Jan 3. Review.

7.

A review of the metabolic syndrome.

Balkau B, Valensi P, Eschwège E, Slama G.

Diabetes Metab. 2007 Dec;33(6):405-13. Epub 2007 Nov 5. Review.

8.

Insulin resistance as the underlying cause for the metabolic syndrome.

Lann D, LeRoith D.

Med Clin North Am. 2007 Nov;91(6):1063-77, viii. Review.

PMID:
17964909
9.

Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity.

Fam BC, Morris MJ, Hansen MJ, Kebede M, Andrikopoulos S, Proietto J, Thorburn AW.

Diabetes Obes Metab. 2007 Nov;9(6):840-52.

PMID:
17924866
10.

Glucocorticoids, metabolism and metabolic diseases.

Vegiopoulos A, Herzig S.

Mol Cell Endocrinol. 2007 Sep 15;275(1-2):43-61. Epub 2007 Jun 2. Review.

PMID:
17624658
11.

Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.

Vogeser M, König D, Frey I, Predel HG, Parhofer KG, Berg A.

Clin Biochem. 2007 Sep;40(13-14):964-8. Epub 2007 Jun 2.

PMID:
17583689
12.

Adipocytes as regulators of energy balance and glucose homeostasis.

Rosen ED, Spiegelman BM.

Nature. 2006 Dec 14;444(7121):847-53. Review.

14.

Obesity-related derangements in metabolic regulation.

Muoio DM, Newgard CB.

Annu Rev Biochem. 2006;75:367-401. Review.

PMID:
16756496
15.

Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.

Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, Bollheimer LC.

J Mol Endocrinol. 2006 Jun;36(3):485-501.

16.

The life cycle of neutral lipids: synthesis, storage and degradation.

Athenstaedt K, Daum G.

Cell Mol Life Sci. 2006 Jun;63(12):1355-69. Review.

PMID:
16649142
17.

Role of peroxisome proliferator-activated receptor gamma in glucose-induced insulin secretion.

Xu ZK, Chen NG, Ma CY, Meng ZX, Sun YJ, Han X.

Acta Biochim Biophys Sin (Shanghai). 2006 Jan;38(1):1-7.

18.

Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease.

Pulinilkunnil T, Rodrigues B.

Cardiovasc Res. 2006 Feb 1;69(2):329-40. Epub 2005 Nov 22. Review.

19.

Pathophysiology of dyslipidaemia in the metabolic syndrome.

Kolovou GD, Anagnostopoulou KK, Cokkinos DV.

Postgrad Med J. 2005 Jun;81(956):358-66. Review.

20.

Metabolic syndrome: a clinical and molecular perspective.

Moller DE, Kaufman KD.

Annu Rev Med. 2005;56:45-62. Review.

PMID:
15660501
Items per page

Supplemental Content

Write to the Help Desk